Answer
Oct 17, 2025 - 04:44 AM
It has been investigated for sporadic inclusion body myositis (sIBM), sarcopenia, and obesity-related metabolic disorders, particularly in patients with type 2 diabetes and obesity. This is valuable because it highlights the potential range of conditions that may benefit from the treatment.
